Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Over the last two years, the COSECSA Oxford Orthopaedic Link (COOL) programme has supported 48 Primary Trauma Care (PTC) training courses in sub-Saharan Africa, run jointly by NHS and local volunteers.

Over the last two years, the COSECSA Oxford Orthopaedic Link (COOL) programme has supported 48 Primary Trauma Care (PTC) training courses in sub-Saharan Africa, run jointly by NHS and local volunteers.

Trauma is one of the leading causes of death and disability for young people in sub-Saharan Africa, and a key challenge in trauma management is the shortage of trained health workers, particularly in rural areas.

COOL’s courses have trained over 1650 new PTC providers (doctors, nurses, and clinical officers) and 450 new PTC instructors across the 10 countries of the College of Surgeons of East Central and Southern Africa (COSECSA). 

Country representatives from the 10 COSECSA countries met last month to share highlights and challenges from setting up a series of trauma training courses in each country, and to discuss strategies for sustainability. Dr Milliard Derbew, COSECSA Vice-President, thanked the representatives for their commitment to trauma training and expressed COSECSA’s on-going support for the training. [see picture]

Noel Peter, COOL programme researcher and Orthopaedic Specialist Registrar at the Nuffield Orthopaedic Centre, said of the meeting: "It's been wonderful to hear and witness first-hand the impact PTC courses have made to health workers in the region. This is further supported by our own data demonstrating an overall increase in knowledge and clinical confidence of trainees. We are also very encouraged by current efforts by local clinicians to embed trauma training into undergraduate and postgraduate medical curricula."

Trauma was the key theme of the annual COSECSA Annual Scientific Conference in Dar es Salaam a week later, where the COOL programme team presented 6 abstracts on the programme’s work to strengthen trauma and musculoskeletal impairment care in the COSECSA region through PTC training and trauma research.

During the conference, Professor Chris Lavy, project director of COOL, organised a symposium on trauma registries for COSECSA members to share data and lessons learned from existing trauma registries in Mozambique, Tanzania, Rwanda, Cameroon and Malawi. He encouraged more collaboration on trauma data collection across COSECSA countries, so that the data can be used to improve efficiency and quality of trauma care more widely in the region.

COOL is a partnership between NDORMS and COSECSA to support trauma and orthopaedic research, training and capacity building in sub-Saharan Africa. It is funded by the UK Department for International Development through the Health Partnership Scheme.

Click here for the latest project update.

Similar stories

Plaster cast or metal pins to treat a broken wrist? The results are in.

An Oxford study published in The BMJ has found the use of metal K-wires (commonly known as ‘pins’) to hold broken wrist bones in place while they heal are no better than a traditional moulded plaster cast.

Professor Chris Buckley has joined the Kennedy Institute as Director of Clinical Research

Moving to the University of Oxford with the Arthritis Therapy Acceleration Programme (A-TAP) will help accelerate the discovery of new treatments for inflammatory diseases.

Behind enemy lines: research finds a new ally in the fight against cardiovascular disease hidden within the vessel wall itself

A new study reveals the existence of a powerful ally in the fight against cardiovascular disease, a protective subset of vascular macrophages expressing the C-type lectin receptor CLEC4A2, a molecule which fosters “good” macrophage behaviour within the vessel wall.

More effective treatment found for patients hospitalised with COVID-19 pneumonia

A proof-of-concept trial involving Oxford researchers has identified a drug that may benefit some patients hospitalised with COVID-19 pneumonia.

NDORMS researchers honoured in the Recognition Of Distinction Scheme 2021

Sally Hopewell and John Christianson have been awarded the title of ‘Full Professor’ in the University of Oxford’s Recognition Of Distinction Scheme 2021.

New Oxford-Zeiss Centre of Excellence opens at the University of Oxford

The Kennedy Institute for Rheumatology and the Institute of Developmental and Regenerative Medicine announce the launch of the Oxford-Zeiss Centre of Excellence, providing state-of-the-art imaging technologies to lead future discoveries in global health and disease.